Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?

被引：5
|
作者：
Toussirot, Eric [1 ,3 ,4 ]
Khan, Kashif Aziz [2 ,3 ]
Herbein, Georges [2 ,3 ]
机构：
[1] Univ Hosp Jean Minjoz, Dept Rheumatol, F-25000 Besancon, France
[2] Univ Hosp St Jacques, Dept Virol, F-25000 Besancon, France
[3] Univ Franche Comte, UPRES EA Pathogens & Inflammat 4266, F-25000 Besancon, France
[4] Univ Hosp St Jacques, CIC Biotherapy 506, F-25000 Besancon, France
来源：
CLINICAL EPIGENETICS | 2010年 / 1卷
关键词：
D O I：
10.1007/s13148-010-0002-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 6
页数：4
相关论文
共 50 条
  • [1] Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?
    Éric Toussirot
    Kashif Aziz Khan
    Georges Herbein
    Clinical Epigenetics, 2010, 1 : 3 - 6
  • [2] Histone deacetylase inhibitors: New hope for rheumatoid arthritis?
    Choo, Q. Y.
    Ho, P. C.
    Lin, H. S.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (08) : 803 - 820
  • [3] Histone deacetylase inhibitors: A new class of potential therapeutic agents for cancer treatment
    Richon, VM
    O'Brien, JP
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 662 - 664
  • [4] Strategies in Developing Promising Histone Deacetylase Inhibitors
    Zhang, Lei
    Fang, Hao
    Xu, Wenfang
    MEDICINAL RESEARCH REVIEWS, 2010, 30 (04) : 585 - 602
  • [5] Histone deacetylase inhibitors: A new perspective for the treatment of leukemia
    Abujamra, Ana Lucia
    dos Santos, Michel Pinheiro
    Roesler, Rafael
    Schwartsmann, Gilberto
    Brunetto, Algemir Lunardi
    LEUKEMIA RESEARCH, 2010, 34 (06) : 687 - 695
  • [6] Histone Deacetylase Inhibitors as a Promising Treatment Against Myocardial Infarction: A Systematic Review
    Sanchez-Fernandez, Eduardo
    Guerra-Ojeda, Sol
    Suarez, Andrea
    Serna, Eva
    Mauricio, Maria D.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [7] The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment
    Shirbhate, Ekta
    Patel, Preeti
    Patel, Vijay K.
    Veerasamy, Ravichandran
    Sharma, Prabodh C.
    Rajak, Harish
    FUTURE ONCOLOGY, 2020, 16 (30) : 2457 - 2469
  • [8] Histone deacetylase inhibitors: New strategy for the management of rheumatoid arthritis.
    Lin, HS
    Hu, CY
    Chan, HY
    Liew, YY
    Huang, HP
    Lepescheux, L
    Bastianelli, E
    Baron, R
    Clement-Lacroix, P
    Rawadi, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S110 - S110
  • [9] Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?
    Faiao-Flores, Fernanda
    Smalley, Keiran S. M.
    MELANOMA MANAGEMENT, 2019, 6 (04)
  • [10] Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
    Yao, Yiwu
    Tu, Zhengchao
    Liao, Chenzhong
    Wang, Zhen
    Li, Shang
    Yao, Hequan
    Li, Zheng
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (19) : 7672 - 7680
12345